#99 Will the Flu Shot Help my Grandma and Grandpa?
CLINICAL QUESTION
Does the seasonal trivalent influenza vaccine (flu shot) prevent influenza or its complications in patients age ≥65 years old?
BOTTOM LINE
One high quality randomized controlled trial demonstrated that vaccinating 40 community dwelling seniors with the trivalent influenza vaccine (flu shot) will prevent one case of influenza. Cohort studies demonstrating mortality benefits are biased by healthy user effect.
Reading Tools for Practice Article can earn you MainPro+ Credits
Join NowAlready a CFPCLearn Member? Log in
EVIDENCE
Meta-analysis evaluating cohort and randomized controlled studies of influenza vaccine in patients ≥65 years concluded they are unable to determine effectiveness of the vaccine.1
Randomized Controlled Trials (RCTs) of community-dwelling patients:
- Netherlands: Double blinded RCT of flu shot versus placebo in 1,838 patients, mean age 67 years, 87% without previous vaccination.2,3
- Influenza (influenza-like illness plus serology): Vaccine 1.7%, placebo 4.2%, Number Needed to Treat (NNT)=40.
- Mortality rates not reported.
- Adverse events: Local reactions more common, systemic effects similar.3
- United Kingdom: Smaller, single-blinded, less generalizable (729 patients with co-morbidities excluded) placebo-controlled RCT of flu shot after all received pneumococcal vaccine.4
- No difference in influenza, pneumonia, hospitalization for respiratory illness or mortality.
- RCT of 614 nursing home patients: Lower quality, multi-armed, placebo-controlled RCT of flu shot +/- live intranasal vaccine.5
- Only the combination of flu shot plus live intranasal vaccine significantly decreased influenza rates (4.5% versus 12.8% placebo, NNT=13).
- Study appears underpowered to show benefits of other interventions.
- Mortality rates not reported.
- Cohort studies demonstrated large reductions in hospitalizations and mortality, but are confounded by healthy user effect1 as:
- Benefits seen outside of influenza season.
- Overall mortality reduction is greater than reduction in influenza, hospitalizations, and deaths due to respiratory illnesses.
- Based on this observational data, Canadian guidelines recommend vaccinating elderly to decrease influenza related morbidity and mortality.6
- For Canadians ≥65 years, the annual influenza death rate is ~100/100,000.7,8
- Cardiovascular disease and cancer deaths are at least 25 times more common.8
Latest Tools for Practice
#378 Tony Romo-sozumab: Winning touchdown in osteoporosis or interception for the loss?
What is the efficacy and safety of romosozumab in postmenopausal women with osteoporosis?
#377 How to slow the flow IV: Combined oral contraceptives
In premenopausal heavy menstrual bleeding due to benign etiology, do combined oral contraceptives (COC) improve patient outcomes?
#376 Testosterone supplementation for cis-gender men: Let’s (andro-)pause for a moment (Update)
What are the benefits and harms of testosterone supplementation in healthy cis-gender men or those with age-related low testosterone?
